In this regard, five mRNAs (CCND1, LMTK2, FN1, EZH2, and GOLM1) were included in a gene panel for prostate cancer diagnosis and reported as differentially expressed in a Chinese cohort of 281 patients using RT-qPCR from tissue samples [65]. This evidence concerns the gene LMTK2 and prostate cancer.